Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 100,087 shares at $32.70 ($3.2M) on 2026-02-03, disclosed to the SEC on 2026-02-03.
Scheduled sale ($3.2M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.06 | 66,452 | $2.1M | 66.0% |
| 2 | $32.70 | 33,635 | $1.1M | 34.0% |
| Total | $32.28 avg | 100,087 | $3.2M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |